Results 231 to 240 of about 48,098 (265)
Unveiling the Accurate Site-Specific <i>N</i>- and <i>O</i>-Glycosylation of Hyperglycosylated Erythropoietin Drugs by an Integrated Approach. [PDF]
Anal ChemWu S +11 more
europepmc +1 more source
Enhancing Cancer Vaccine Efficacy: Backbone Modification with β‑Amino Acids Alters the Stability and Immunogenicity of MUC1-Derived Glycopeptide Formulations. [PDF]
JACS AuGibadullin R +20 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Medicinal Chemistry, 2001
Resistance to glycopeptides in enterococci, which first emerged in the late 1980's and is now widespread mainly in the United States, is posing a serious clinical problem due to the lack of alternative and efficacious therapeutic options, particularly against infections caused by VanA strains that are highly resistant to glycopeptides and almost all ...
A, Malabarba, R, Ciabatti
openaire +2 more sources
Resistance to glycopeptides in enterococci, which first emerged in the late 1980's and is now widespread mainly in the United States, is posing a serious clinical problem due to the lack of alternative and efficacious therapeutic options, particularly against infections caused by VanA strains that are highly resistant to glycopeptides and almost all ...
A, Malabarba, R, Ciabatti
openaire +2 more sources
ChemInform, 2005
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Mickael Mogemark, Jan Kihlberg
openaire +1 more source
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Mickael Mogemark, Jan Kihlberg
openaire +1 more source
The Journal of Clinical Pharmacology, 1988
Numerous glycopeptides continue to be described in the literature. They all share a similar heptapeptidic structure with a fixed spatial configuration that forms the basis of their ability to recognize D-alanyl-D-alanine-containing structures in the cell wall.
openaire +2 more sources
Numerous glycopeptides continue to be described in the literature. They all share a similar heptapeptidic structure with a fixed spatial configuration that forms the basis of their ability to recognize D-alanyl-D-alanine-containing structures in the cell wall.
openaire +2 more sources
1998
Abstract Vancomycin is the only glycopeptide antibiotic licensed for clinical use in the United States. Another glycopeptide antibiotic, teicoplanin, is currently in clinical use in Europe, where, in addition, the glycopeptide avoparcin has been used in chicken and ruminant livestock feed as a growth promoter.
Adel S Sulaiman +2 more
openaire +1 more source
Abstract Vancomycin is the only glycopeptide antibiotic licensed for clinical use in the United States. Another glycopeptide antibiotic, teicoplanin, is currently in clinical use in Europe, where, in addition, the glycopeptide avoparcin has been used in chicken and ruminant livestock feed as a growth promoter.
Adel S Sulaiman +2 more
openaire +1 more source